Figure 4From: Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrineUV spectra recorded for lumefantrine (left) and DBK (right) showing the observed wavelength of maximum absorption. DAD-UV spectra of lumefantrine (left) and DBK (right).Back to article page